Fennec Pharmaceuticals
FENC
52 hedge funds and large institutions have $108M invested in Fennec Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 10 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
29% more capital invested
Capital invested by funds: $83.8M → $108M (+$24M)
1.56% more ownership
Funds ownership: 54.54% → 56.1% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 55 → 52 (-3)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Sonic Fund II
Honolulu,
Hawaii
|
+$6.08M |
| 2 |
BlackRock
New York
|
+$245K |
| 3 |
Morgan Stanley
New York
|
+$108K |
| 4 |
State Street
Boston,
Massachusetts
|
+$97.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$417K |
| 2 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$307K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$279K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$164K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$147K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WS
51
Wedbush Securities
Los Angeles,
California
| – | -$417K | -68,893 | Closed |
|
|
MAM
52
Martingale Asset Management
Boston,
Massachusetts
| – | -$307K | -50,613 | Closed |
|
|
WMSA
53
Weiss Multi-Strategy Advisers
New York
| – | -$147K | -24,237 | Closed |
|
|
GCP
54
GSA Capital Partners
London,
United Kingdom
| – | -$136K | -22,385 | Closed |
|
55
Ameriprise
Minneapolis,
Minnesota
| – | -$86K | -14,090 | Closed |
|
56
HSBC Holdings
London,
United Kingdom
| – | -$60K | -10,183 | Closed |
|
|
MAM
57
Meeder Asset Management
Dublin,
Ohio
| – | -$8K | -1,310 | Closed |
|
|
APA
58
American Portfolios Advisors
Holbrook,
New York
| – | -$4.54K | -750 | Closed |
|
|
FDCDDQ
59
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$4.24K | -700 | Closed |
|
|
EI
60
Ellevest Inc
New York
| – | +$503 | +66 | New |
|
FENC Hedge Fund Activity: Q4 2020 in Review
52 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q4 2020, worth a combined $108M — up 29% from $83.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FENC and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 20 added.
The largest buyer was Sonic Fund II, adding an estimated $6.08M. The largest seller was Wedbush Securities, exiting entirely with an estimated $417K sold.
- 52 institutional investors held Fennec Pharmaceuticals (FENC) as of Q4 2020, down from 55 in Q3 2020.
- Funds reported $108M of Fennec Pharmaceuticals stock for Q4 2020, up 29% quarter-over-quarter.
- 8 funds opened new Fennec Pharmaceuticals positions in Q4 2020 and 10 closed out, a net change of -2 holders.
- The largest Fennec Pharmaceuticals buyer in Q4 2020 was Sonic Fund II, an estimated $6.08M added.
- The largest Fennec Pharmaceuticals seller in Q4 2020 was Wedbush Securities, an estimated $417K sold.
Based on aggregated 13F filings for Q4 2020.